Longeveron (LGVN) Q2 2026 Earnings Call Transcript
ELPIS II trial data expected September 2026 as cash runway extends into Q4.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
CuriosityStream (CURI) Q2 2026 Earnings Call Transcript
Licensing revenue surged 48% as AI training deals accelerated.
Journey Medical (DERM) Q2 2026 Earnings Call Transcript
Emrosi prescriptions hit 14,000 in July as payer coverage expands and margins improve.
News of the day: Summer of the Iceman, Churchill Falls deal, Moneris sale concerns, income tax reporting failure, retirement planning and more
Catch up on the stories we’re following today
US national debt surpasses $40 trillion for first time
The record milestone underscores the mounting cost of government borrowing as Washington faces growing spending demands and rising interest payments.
Wealthy investors rethink retirement as 27% plan to work for as long as possible
Wealthy investors are rethinking retirement and wealth planning as longer lives reshape investment, succession, healthcare and family strategies, research finds